Verily Stock

Verily develops tools and devices to collect, organize and activate health data.

Sign up today and learn more about Verily Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Verily Stock

Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.

Funding History

January 2017$800M
January 2019$1.0B


Product Manager

Collin Walter

Head of Engineering

Linus Upson


Andy Conrad


Duncan Welstead

Chief Medical Officer & C0-Founder

Jessica Mega

Head of People Operations

Sheela Krothapalli

Chief Technical Officer

Brian Otis


Deepak Ahuja

Head of Talent Acquisition

Kelly Gutilla

Chief Operating Officer

Ashraf Hanna


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: